Pharmacokinetics and pharmacodynamics of a polyethylene glycol (PEG)-conjugated GLP-receptor agonist once weekly in Chinese patients with type 2 diabetes
canephora robusta, seed, 45% chlorogenic acids): 200 mg L-carnitine L-tartrate: 100 mg L-theanine: 100 mg Cocoa extract (Theobroma cacao, seed, 6% theobromine): 100 mg Black pepper extract (Piper nigrum, fruit, 95% piperine): 5 mg Cayenne pepper (Capsicum annuum, fruit): 5 mg *RI - Reference Intake Ingredients: Veggie capsule (hypromellose, titanium dioxide), cellulose, silicon dioxide, magnesium stearate, caffeine anhydrous, green coffee extract, L-carnitine L-tartrate, L-theanine, cocoa extract, black pepper extract, cayenne pepper
Documentation should include symptom history, ankle-brachial index (ABI) results if available, imaging if available, and an ICD-10 code (often I70.21 or I73.9)
Avalos, I
Presented for research literature review only Oskinis S et al
GLP-1 Receptor Agonists Various large cardiovascular outcome studies have shown a reduction in cardiovascular endpoints with GLP-1 receptor agonists [69]